These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 526011)

  • 1. Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice.
    Descamps J; De Clercq E; Barr PJ; Jones AS; Walker RT; Torrence PF; Shugar D
    Antimicrob Agents Chemother; 1979 Nov; 16(5):680-2. PubMed ID: 526011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    de Clercq E
    Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-5-(2-bromovinyl)-2'-deoxyuridine vs. interferon in the systemic treatment of infection with herpes simplex virus of athymic nude mice.
    De Clercq E; Zhen-Xi Z; Descamps J; Huygen K
    J Infect Dis; 1981 Jun; 143(6):846-52. PubMed ID: 6166694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice.
    De Clercq E; Holý A
    Antimicrob Agents Chemother; 1991 Apr; 35(4):701-6. PubMed ID: 2069375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous herpes simplex virus infections.
    Arbesfeld DM; Thomas I
    Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo.
    De Clercq E; Holý A; Rosenberg I
    Antimicrob Agents Chemother; 1989 Feb; 33(2):185-91. PubMed ID: 2719463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
    Klein RJ; Friedman-Kien AE; Brady E
    Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
    de Clercq E; Zhang ZX; Sim IS
    Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
    De Clercq E; Descamps J; De Somer P; Barr PJ; Jones AS; Walker RT
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2947-51. PubMed ID: 223163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Helbig B; Sauerbrei A; Klöcking R; Wutzler P; Wicht N; Wiedemann U; Herrmann G
    J Med Virol; 1987 Nov; 23(3):303-9. PubMed ID: 2828526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex viruses.
    Ellis MN; Lobe DC; Spector T
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1691-6. PubMed ID: 2556074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection.
    Pancic F; Steinberg BA; Diana GD; Carabateas PM; Gorman WG; Came PE
    Antimicrob Agents Chemother; 1981 Mar; 19(3):470-6. PubMed ID: 7247370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1985 Jul; 28(1):103-6. PubMed ID: 4037770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
    Yamamoto M; Hayashi Y; Tang LL; Mori R
    Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.